Metabolomics in paediatric oncology: A potential still to be exploited

Laura Spiga, Luigi Atzori, Antonio Noto, Corrado Moretti, Michele Mussap, Alice Masile, Milena Lussu, Vassilios Fanos

Research output: Contribution to journalArticle

Abstract

Oncology is a branch of medicine in rapid evolution in the attempt to find innovative methods for early diagnosis and a better understanding of tumoral processes leading to the development of new therapies. Metabolomics is the emerging discipline among the "omics" sciences which makes it possible to further expand our knowledge concerning cancer biology. Different studies have revealed the potential role of metabolomics in gaining an understanding of pathophysiological processes in cancer, improving tumor staging, characterizing tumors and searching for biomarkers predictive of therapeutic responses. However, to date there are few works aimed at gaining deeper insights into infantile oncology through metabolomics.

Original languageEnglish
Pages (from-to)20-23
Number of pages4
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume26
Issue numberSUPPL.2
DOIs
Publication statusPublished - Oct 2013

    Fingerprint

Keywords

  • Metabolomics
  • Oncology
  • Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Spiga, L., Atzori, L., Noto, A., Moretti, C., Mussap, M., Masile, A., Lussu, M., & Fanos, V. (2013). Metabolomics in paediatric oncology: A potential still to be exploited. Journal of Maternal-Fetal and Neonatal Medicine, 26(SUPPL.2), 20-23. https://doi.org/10.3109/14767058.2013.832062